For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250423:nRSW9169Fa&default-theme=true
RNS Number : 9169F Smithson Investment Trust PLC 23 April 2025
Smithson Investment Trust plc
Legal Entity Identifier: 52990070BDK2OKX5TH79
Results of AGM - 23 April 2025
Smithson Investment Trust plc (the "Company") is pleased to announce that all
the resolutions put forward at its Annual General Meeting held earlier today
were passed.
The text of all the resolutions is contained in the Notice of Annual General
Meeting published on the Company's website (www.smithson.co.uk).
The proxy votes received were as follows:-
Resolution In Favour / Discretionary Against Withheld
Votes % Votes % Votes
1. To receive and accept the Annual Report and Accounts for the year ended 31 41,443,539 99.98% 8,092 0.02% 11,296
December 2024.
2. To approve the Directors' Remuneration Report. 40,987,664 98.95% 436,326 1.05% 38,937
3. To approve a final dividend of 0.58p per ordinary share in respect of the year 41,126,417 99.21% 326,294 0.79% 10,216
ended 31 December 2024, to be paid on 2 May 2025.
4. To elect Mike Balfour as a Director of the Company. 40,417,038 97.62% 983,293 2.38% 62,596
6. To re-elect Jeremy Attard-Manche as a Director of the Company. 38,579,295 96.66% 1,333,071 3.34% 1,709,040
7. To re-elect Denise Hadgill as a Director of the Company. 38,869,090 97.38% 1,045,102 2.62% 1,707,214
8. To re-appoint Deloitte LLP as auditor to the Company. 41,190,787 99.11% 369,141 0.89% 61,478
9. To authorise the Directors to fix the remuneration of the auditor until the 41,087,522 99.16% 349,051 0.84% 26,354
conclusion of the next AGM.
10. That the amendment to the Company's investment policy be approved. 41,202,659 99.07% 387,490 0.93% 31,257
11. To authorise the Directors to allot up to 10% of the issued ordinary share 41,146,126 98.91% 451,603 1.09% 23,677
capital of the Company as at 3 March 2025.
12. In addition to 11, to authorise the Directors to allot up to 10% of the issued 41,140,844 98.90% 455,783 1.10% 24,779
ordinary share capital as at 3 March 2025.
13. To disapply the pre-emption rights in relation to the allotment of shares 40,712,908 97.87% 884,960 2.13% 23,538
under resolution 11.*
14. To disapply the pre-emption rights in relation to the allotment of shares 40,682,140 97.80% 914,665 2.20% 24,601
under resolution 12. *
15. To authorise the Company to make market purchases of ordinary shares in the 40,083,285 96.71% 1,362,436 3.29% 17,206
Company. *
16. To authorise the Directors to call general meetings (other than AGMs) on not 41,178,737 98.98% 423,772 1.02% 18,897
less than 14 clear days' notice.*
17. That the Company continues in being as an investment trust. 36,180,359 96.24% 1,413,870 3.76% 2,506,175
*Special resolution
On the 17 April 2025, the record date for voting at the meeting, the Company's
issued share capital consisted of 177,107,958 ordinary shares. There were
55,052,978 ordinary shares held in treasury. The total number of ordinary
shares with voting rights in the Company was 122,054,980.
Copies of all the resolutions passed, other than ordinary business, will be
submitted to the National Storage Mechanism and will shortly be available for
inspection at:- https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism)
23 April 2025
Enquiries
Apex Listed Companies Services (UK) Limited
Company Secretary
t: +44 20 3994 7161
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END RAGUOUVRVRUSUAR